بديل نوفوسيفين 1.2مجم فيال
بديل Novoseven 1.2mg i.v. vial(n/a)

تم البحث عن بدائل هذا الدواء 253 مرة


بدايل دواء نوفوسيفين 1.2مجم فيال Novoseven 1.2mg i.v. vial(n/a)

مرحباً بكم في موقع دليل الدواء الجديد، وتحديداً في صفحة دواء نوفوسيفين 1.2مجم فيال
يعد دواء نوفوسيفين 1.2مجم فيال من أفضل وأقوى الأدوية التي يتم صرفها واستخدامها في علاج blood coagulation factor novoseven�is recombinant human coagulation factor viia (rfviia) intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade. novoseven (coagulation factor viia recombinant) is a vitamin k-dependent glycoprotein consisting of 406 amino acid residues (mw 50 k dalton). novoseven (coagulation factor viia recombinant) is structurally similar to human plasma-derived factor viia. - -indications: -*treatment of bleeding episodes in hemophilia a or b patients with inhibitors to factor viii or factor ix and in patients with acquired hemophilia. -*prevention of bleeding in surgical interventions or invasive procedures in hemophilia a or b patients with inhibitors to factor viii or factor ix and in patients with acquired hemophilia. -*treatment of bleeding episodes in patients with congenital fvii deficiency. -*prevention of bleeding in surgical interventions or invasive procedures in patients with congenital fvii deficiency، حيث أنه يحتوي على مادة فعالة وتركيبة قوية جداً في علاج مثل هذه الحالات ألا وهي

blood-coagulation factor vii.

يتوفر دواء نوفوسيفين 1.2مجم فيال في السوق بسعر 5127 وهو من إنتاج شركة novo nordisk ومن أشهر بدائل دواء نوفوسيفين 1.2مجم فيال


injection
blood-coagulation factor viii

green-viii inj. 250 i.u./vial.

اذهب الى الدواء
injection
blood-coagulation factor viii

dried factor viii fraction 8y 250i.u./10ml vial

اذهب الى الدواء
injection
blood-coagulation factor viii

koate-dvi 250 iu i.v. vial 5 ml

اذهب الى الدواء
injection
blood-coagulation factor viii

haemoctin sdh 250i.u./ml

اذهب الى الدواء
injection
blood-coagulation factor viii

dried factor viii fraction 8y 500i.u./20ml vial

اذهب الى الدواء
injection
blood-coagulation factor viii

beriate p 250i.u. vial

اذهب الى الدواء
injection
blood-coagulation factor viii

xyntha 250 i.u. lyophilized powder vial

اذهب الى الدواء
injection
blood-coagulation factor viii

beriate p 500i.u. vial

اذهب الى الدواء
injection
blood-coagulation factor viii

koate-dvi 500 iu i.v. vial 5 ml

اذهب الى الدواء
injection
blood-coagulation factor viii

novoeight 250 i.u. i.v. vial+prefilled syringe

اذهب الى الدواء
injection
blood-coagulation factor viii

kogenate-fs 250 iu i.v. infusion vial 2.5 ml

اذهب الى الدواء
injection
blood-coagulation factor viii

xyntha 500 i.u. lyophilized powder vial

اذهب الى الدواء
injection
blood-coagulation factor vii

novoseven 1.2mg i.v. vial(n/a)

اذهب الى الدواء
injection
blood-coagulation factor viii

novoeight 500 i.u. i.v. vial+prefilled syringe

اذهب الى الدواء
injection
blood-coagulation factor viii

kogenate-fs 500 iu i.v. infusion vial 2.5 ml

اذهب الى الدواء
injection
blood-coagulation factor viii

xyntha 1000 i.u. lyophilized powder vial

اذهب الى الدواء
injection
blood-coagulation factor vii

novoseven 1mg i.v. vial

اذهب الى الدواء

سعر دواء نوفوسيفين 1.2مجم فيال

5127 جنيه

All You Need To Know About novoseven 1.2mg i.v. vial(n/a)

Welcome to Dlildwa, specifically the page of novoseven 1.2mg i.v. vial(n/a).

  • novoseven 1.2mg i.v. vial(n/a) is a highly effective medication that is used to treat a variety of conditions. It contains blood-coagulation factor vii, which is the active ingredient that provides the drug's therapeutic effect.
  • This medication is typically prescribed to treat blood coagulation factor, which include novoseven�is recombinant human coagulation factor viia (rfviia) intended for promoting hemostasis by activating the extrinsic pathway of the coagulation cascade. novoseven (coagulation factor viia recombinant) is a vitamin k-dependent glycoprotein consisting of 406 amino acid residues (mw 50 k dalton). novoseven (coagulation factor viia recombinant) is structurally similar to human plasma-derived factor viia. - -indications: -*treatment of bleeding episodes in hemophilia a or b patients with inhibitors to factor viii or factor ix and in patients with acquired hemophilia. -*prevention of bleeding in surgical interventions or invasive procedures in hemophilia a or b patients with inhibitors to factor viii or factor ix and in patients with acquired hemophilia. -*treatment of bleeding episodes in patients with congenital fvii deficiency. -*prevention of bleeding in surgical interventions or invasive procedures in patients with congenital fvii deficiency. It is known for its potent formula and fast-acting nature, making it a popular choice among healthcare providers and patients alike.
  • novoseven 1.2mg i.v. vial(n/a) is produced by novo nordisk and is available in the market at a price of 5127. It is one of the most popular and trusted medications in its class, and is often recommended by doctors for its safety and effectiveness.
  • Before taking , it is important to consult with your healthcare provider to ensure that it is safe and appropriate for your condition. Be sure to follow the dosage instructions carefully, and do not exceed the recommended dose.
  • If you have any questions or concerns about novoseven 1.2mg i.v. vial(n/a) or any other medications, please don't hesitate to contact us. Our team of healthcare professionals is here to help you make informed decisions about your health and wellness.

  • كتب طبية هامة